Evaxion Biotech Ownership | Who Owns Evaxion Biotech?
Evaxion Biotech Ownership Summary
Evaxion Biotech is owned by 381.81% institutional investors, 17.47% insiders. J. safra sarasin is the largest institutional shareholder, holding 5.49% of EVAX shares. PSM Macro Strategy is the top mutual fund, with 0.92% of its assets in Evaxion Biotech shares.
EVAX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Evaxion Biotech | 381.81% | 17.47% | -299.28% |
| Sector | Healthcare Stocks | 246.48% | 12.12% | -158.60% |
| Industry | Biotech Stocks | 384.82% | 11.76% | -296.58% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| J. safra sarasin | 22.90K | 5.49% | $75.10K |
| Smartharvest portfolios | 17.96K | 4.31% | $58.91K |
| Wesbanco bank | 10.00K | 2.40% | $32.80K |
| Ikarian capital | 74.70K | 0.90% | $277.88K |
| Rathbones group | 45.72K | 0.55% | $170.09K |
| Renaissance | 39.23K | 0.47% | $145.92K |
| Annis gardner whiting capital advisors | 30.00K | 0.36% | $111.60K |
| Xtx topco | 22.05K | 0.26% | $82.04K |
| Rhumbline advisers | 21.66K | 0.26% | $80.56K |
| Stonepine capital management | 19.71K | 0.24% | $73.33K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Stonepine capital management | 19.71K | 0.03% | $73.33K |
| Smartharvest portfolios | 17.96K | 0.02% | $58.91K |
| Ikarian capital | 74.70K | 0.02% | $277.88K |
| Annis gardner whiting capital advisors | 30.00K | 0.02% | $111.60K |
| Xtx topco | 22.05K | 0.00% | $82.04K |
| J. safra sarasin | 22.90K | 0.00% | $75.10K |
| Wesbanco bank | 10.00K | 0.00% | $32.80K |
| Boothbay fund management | 18.43K | 0.00% | $68.55K |
| Gamma investing | 5.20K | 0.00% | $19.34K |
| Rathbones group | 45.72K | 0.00% | $170.09K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rathbones group | 45.72K | 0.00% | 45.72K |
| Renaissance | 39.23K | 0.00% | 39.23K |
| Annis gardner whiting capital advisors | 30.00K | 0.02% | 30.00K |
| Xtx topco | 22.05K | 0.00% | 22.05K |
| Citadel advisors | 17.77K | - | 17.77K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | - | - | -33.10K |
| Royal bank of canada | - | - | -3.90K |
| Ubs group | - | - | -3.22K |
| Eversource wealth advisors | - | - | -2.27K |
| Stonepine capital management | 19.71K | 0.03% | -287.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Rathbones group | 45.72K | 0.00% | 45.72K | $170.09K |
| Renaissance | 39.23K | 0.00% | 39.23K | $145.92K |
| Annis gardner whiting capital advisors | 30.00K | 0.02% | 30.00K | $111.60K |
| Xtx topco | 22.05K | 0.00% | 22.05K | $82.04K |
| Citadel advisors | 17.77K | - | 17.77K | $66.12K |
Sold Out
| Holder | Change |
|---|---|
| Eversource wealth advisors | -2.27K |
| Ubs group | -3.22K |
| Royal bank of canada | -3.90K |
| Point72 asset management | -33.10K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 19 | 26.67% | 1,592,195 | 384.53% | 381 | 6.15% | 7 | - | 5 | 66.67% |
| Mar 31, 2026 | 15 | 15.38% | 328,604 | 53.38% | 3 | 35.25% | 7 | -30.00% | 3 | - |
| Dec 31, 2025 | 13 | 116.67% | 214,235 | 83.83% | 3 | 101.08% | 10 | 900.00% | 3 | 50.00% |
| Sep 30, 2025 | 6 | -25.00% | 116,537 | -2.69% | 1 | 52.07% | 1 | - | 2 | -33.33% |
| Jun 30, 2025 | 8 | -11.11% | 119,755 | -12.63% | 1 | 40.85% | 1 | -87.50% | 3 | 200.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| PSM Macro Strategy | 83.31K | 0.92% | - |
| PSM Value Strategy UI | 79.95K | 0.89% | - |
| NewDeal Invest, kl n | 15.74K | 0.27% | - |
| PSM Growth UI | 4.97K | 0.06% | 4.97K |
| Fidelity Nasdaq Composite Index | 621.00 | 0.01% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q1 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
| 2023 Q1 | - | - |
EVAX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools